BNP/CALL/CARL ZEISS MEDITEC/150/0.1/19.12.25 Stock

Warrant

DE000PC6MD46

Market Closed - Börse Stuttgart 12:12:43 2024-06-20 pm EDT
0.12 EUR -7.69% Intraday chart for BNP/CALL/CARL ZEISS MEDITEC/150/0.1/19.12.25
Current month-60.00%
1 month-78.18%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-20 0.12 -7.69%
24-06-19 0.13 -7.14%
24-06-18 0.14 -6.67%
24-06-17 0.15 -53.12%
24-06-14 0.32 +3.23%

Delayed Quote Börse Stuttgart

Last update June 20, 2024 at 12:12 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CARL ZEISS MEDITEC AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC6MD4
ISINDE000PC6MD46
Date issued 2024-03-14
Strike 150
Maturity 2025-12-19 (547 Days)
Parity 10 : 1
Emission price 1.11
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.6
Lowest since issue 0.12
Spread 0.03
Spread %20.00%

Company Profile

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.
Sector
-
More about the company

Ratings for Carl Zeiss Meditec AG

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Carl Zeiss Meditec AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
66.05 EUR
Average target price
89.6 EUR
Spread / Average Target
+35.65%
Consensus